Notably, strong ppERK increase in drug-treated cells was observed in response to even low levels of light (8 mW/cm2), a level that did not provide measurable increase in untreated cells, suggesting that ALK inhibition can sensitize cancer cells to weak RTK signals (Supplementary Fig. S1B). The gene discussed is ALK; the disease is cancer.